Philips Lumea IPL 7000 by Koninklijke Philips N.V. - long-term hair removal at home

Philips Lumea IPL 7000 hums softly on the bathroom counter, its curved white body warm in the hand and the treatment window glowing amber against the skin. The first flash is a quick pulse of light and a faint plasticky scent, more curiosity than drama.

How Philips positions Lumea IPL

Philips markets the Lumea IPL 7000 series as an at-home intense pulsed light system designed to reduce hair growth on legs, arms, bikini line and face over the long term. The company says selected models in the 7000 range can deliver up to 12 months of hair reduction after the first three treatments when used as directed.

The device is fully cordless in its core configuration, runs on a rechargeable lithium battery and offers five energy settings so users can adjust intensity to skin comfort. Philips highlights built-in SmartSkin guidance that suggests a suitable light setting after a simple skin-tone test, a feature product manager Sanne van den Berg often points to when explaining why many consumers feel more confident starting IPL at home.

Key features and use cases

The Lumea IPL 7000 line includes multiple attachments tailored to body regions, for example a larger curved window for legs and smaller, more precise heads for the upper lip and bikini area. A typical treatment schedule combines an initial phase of four sessions every two weeks with touch-ups every four to eight weeks, depending on hair and body area.

Philips stresses that Lumea devices are intended for naturally dark blonde, brown and black hair on light to medium skin tones, and are not suitable for very dark skin or very light hair because IPL targets melanin contrast. The company advises users to shave before treatment but avoid epilation or waxing, as IPL relies on hair roots being present under the skin surface.

Safety concept and guidance

Safety is a central part of Philips messaging around Lumea IPL. The devices integrate safety sensors that prevent flashes when the treatment window is not fully in contact with the skin, reducing stray light exposure. Each flash lasts fractions of a second and users are advised not to treat tattoos, dark moles or areas with infections.

CEO Roy Jakobs has repeatedly framed consumer health products like Lumea as an extension of Philips long-standing expertise with medical-grade light technologies in professional settings. That positioning matters when retailers talk to customers who hesitate about IPL and want reassurance that a big industrial name stands behind the hardware and testing.

Market, pricing and availability

Philips sells the Lumea IPL 7000 devices under different sub-codes in Europe and other regions, often bundled with travel pouches or extra attachments. On Philips own German website, comparable Lumea IPL models typically sit in a price bracket around 350 to 500 euros, depending on configuration and promotion periods. This places them above simple epilators but below professional salon treatment packages over a multi-year use horizon.

In retail channels, Lumea IPL gets shelf space next to Braun and other IPL brands, with marketing focusing on the promise of visibly reduced regrowth after several rounds rather than instant smoothness. Real-world reviews often mention the subtle warmth on the skin after treatment and a slight rubbery feel of the grip, small tactile details that can influence whether consumers regularly pull the device from the drawer or leave it buried.

Role within Philips and stock context

Consumer beauty hardware like Lumea IPL sits inside Philips personal health segment, which the group highlights in its investor materials as a steady contributor alongside oral care and mother & child care. While the company now focuses heavily on professional health systems and monitoring technologies, Philips still relies on recognizable household products to keep its brand in front of everyday consumers. The Koninklijke Philips N.V. stock trades on Euronext Amsterdam in euros and this segment forms one of several pillars behind the valuation.